| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 2541 |
|---|
| 5 | 5 | | To require the Nuclear Regulatory Commission to revise its regulations to |
|---|
| 6 | 6 | | protect patients from unintended exposure to radiation during nuclear |
|---|
| 7 | 7 | | medicine procedures, and for other purposes. |
|---|
| 8 | 8 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 9 | 9 | | APRIL1, 2025 |
|---|
| 10 | 10 | | Mr. D |
|---|
| 11 | 11 | | AVISof North Carolina (for himself, Mr. GRIFFITH, and Mr. CLINE) |
|---|
| 12 | 12 | | introduced the following bill; which was referred to the Committee on En- |
|---|
| 13 | 13 | | ergy and Commerce |
|---|
| 14 | 14 | | A BILL |
|---|
| 15 | 15 | | To require the Nuclear Regulatory Commission to revise |
|---|
| 16 | 16 | | its regulations to protect patients from unintended expo- |
|---|
| 17 | 17 | | sure to radiation during nuclear medicine procedures, |
|---|
| 18 | 18 | | and for other purposes. |
|---|
| 19 | 19 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 20 | 20 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 21 | 21 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 22 | 22 | | This Act may be cited as the ‘‘Nuclear Medicine Clar-4 |
|---|
| 23 | 23 | | ification Act of 2025’’. 5 |
|---|
| 24 | 24 | | VerDate Sep 11 2014 04:41 Apr 04, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2541.IH H2541 |
|---|
| 25 | 25 | | kjohnson on DSK7ZCZBW3PROD with $$_JOB 2 |
|---|
| 26 | 26 | | •HR 2541 IH |
|---|
| 27 | 27 | | SEC. 2. MEDICAL EVENT REPORTING OF UNINTENDED IR-1 |
|---|
| 28 | 28 | | RADIATION. 2 |
|---|
| 29 | 29 | | (a) R |
|---|
| 30 | 30 | | EVISION OFREGULATIONSREQUIRED.—Not 3 |
|---|
| 31 | 31 | | later than 120 days after the date of enactment of this 4 |
|---|
| 32 | 32 | | Act, the Nuclear Regulatory Commission shall revise sec-5 |
|---|
| 33 | 33 | | tion 35.3045(a)(1) of title 10, Code of Federal Regula-6 |
|---|
| 34 | 34 | | tions, by adding at the end the following: 7 |
|---|
| 35 | 35 | | ‘‘(iv) A dose that is due to an extravasation and ex-8 |
|---|
| 36 | 36 | | ceeds— 9 |
|---|
| 37 | 37 | | ‘‘(A) 0.5 Sv (50 rem) dose equivalent to the 5 cubic 10 |
|---|
| 38 | 38 | | centimeter volume of tissue receiving the highest absorbed 11 |
|---|
| 39 | 39 | | dose during residence time; or 12 |
|---|
| 40 | 40 | | ‘‘(B) 0.5 Sv (50 rem) shallow dose equivalent to the 13 |
|---|
| 41 | 41 | | contiguous 10 square centimeters of skin receiving the 14 |
|---|
| 42 | 42 | | highest absorbed dose during residence time.’’. 15 |
|---|
| 43 | 43 | | (b) E |
|---|
| 44 | 44 | | FFECTIVEDATE.—The revision required under 16 |
|---|
| 45 | 45 | | subsection (a) shall take effect on the date that is 18 17 |
|---|
| 46 | 46 | | months after the date of enactment of this Act. 18 |
|---|
| 47 | 47 | | Æ |
|---|
| 48 | 48 | | VerDate Sep 11 2014 04:41 Apr 04, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\H2541.IH H2541 |
|---|
| 49 | 49 | | kjohnson on DSK7ZCZBW3PROD with $$_JOB |
|---|